Literature DB >> 15876456

Novelty reward as a measure of anhedonia.

Rick A Bevins1, Joyce Besheer.   

Abstract

A decrease in sensitivity to pleasurable stimuli, anhedonia, is a major symptom of depression in humans. Several animal models have been developed to simulate this symptom (e.g. drug withdrawal, learned helplessness) using reward-sensitive procedures such as intracranial self-stimulation and progressive ratio responding as a measure of reward function. Recently, we introduced the use of another procedure, novel-object place conditioning in rats, to measure reward function in an associative learning situation. Withdrawal from chronic nicotine blocked a place preference conditioned by access to novel objects. This blockade was not due to impairment of object interaction, general activity, novelty detection, environmental familiarization, or expression of learning. Consequently, nicotine withdrawal directly reduced the rewarding properties of novelty. It is proposed that the novel-object place conditioning procedure could be usefully extended to other experimental situations and to genetically altered mice, so as to better understand the processes underlying changes in reward function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876456     DOI: 10.1016/j.neubiorev.2005.03.013

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  20 in total

1.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

2.  Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function.

Authors:  G C Harris; M Hummel; M Wimmer; S D Mague; G Aston-Jones
Journal:  Neuroscience       Date:  2007-06-07       Impact factor: 3.590

Review 3.  Natural rewards, neuroplasticity, and non-drug addictions.

Authors:  Christopher M Olsen
Journal:  Neuropharmacology       Date:  2011-04-01       Impact factor: 5.250

Review 4.  Drug abstinence: exploring animal models and behavioral treatment strategies.

Authors:  Joshua A Peck; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2014-03-16       Impact factor: 4.530

5.  Higher sensitivity to the conditioned rewarding effects of cocaine and MDMA in High-Novelty-Seekers mice exposed to a cocaine binge during adolescence.

Authors:  A Mateos-García; C Roger-Sánchez; M Rodriguez-Arias; J Miñarro; M A Aguilar; C Manzanedo; M C Arenas
Journal:  Psychopharmacology (Berl)       Date:  2014-06-08       Impact factor: 4.530

6.  Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice.

Authors:  Chiara Ceci; Virginia Mela; Simone Macrì; Eva M Marco; Maria-Paz Viveros; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2013-12-06       Impact factor: 4.530

7.  Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex.

Authors:  Kelly A Bordner; Robert R Kitchen; Becky Carlyle; Elizabeth D George; Milind C Mahajan; Shrikant M Mane; Jane R Taylor; Arthur A Simen
Journal:  Exp Gerontol       Date:  2011-03-29       Impact factor: 4.032

Review 8.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

9.  Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes.

Authors:  Christina Ginkel; Dieter Hartmann; Katharina vom Dorp; Armin Zlomuzica; Hany Farwanah; Matthias Eckhardt; Roger Sandhoff; Joachim Degen; Mariona Rabionet; Ekrem Dere; Peter Dörmann; Konrad Sandhoff; Klaus Willecke
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

10.  Perirhinal Cortex mGlu5 Receptor Activation Reduces Relapse to Methamphetamine Seeking by Restoring Novelty Salience.

Authors:  Jamie Peters; Michael D Scofield; Shannon M Ghee; Jasper A Heinsbroek; Carmela M Reichel
Journal:  Neuropsychopharmacology       Date:  2015-09-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.